The quick price picture
GLP-1 pricing can look simple in an advertisement and complicated at checkout. A medication price may sit beside a membership charge. A low entry price may apply only to a certain program. Insurance can change the amount a person pays.
As of 2026, brand list prices for Wegovy and Zepbound are roughly $1,000 to $1,349 per month without insurance. NovoCare advertises a $199 per month entry tier for Wegovy. Ro offers Wegovy for $199 per month plus a $149 membership. Compounded semaglutide is still sold by some telehealth companies for roughly $196 to $499 per month.
These figures are a snapshot, not a quote for every reader. Prices, eligibility, included services, and insurance coverage can change.
Compare the monthly figures
- NovoCare Wegovy: $199 per month at the entry tier.
- Ro Wegovy: $199 per month plus a $149 membership, for a combined listed monthly amount of $348.
- Compounded semaglutide from some telehealth companies: roughly $196 to $499 per month.
- Wegovy or Zepbound brand list price without insurance: roughly $1,000 to $1,349 per month.
The lowest medication number is not always the full monthly number. Check for membership, visit, lab, refill, shipping, or cancellation costs before signing up. The facts available here confirm the Ro membership fee but do not establish those other fees for every service.
Brand list price is not always your price
List price is a useful reference, but it does not tell every patient what they will pay. The verified 2026 range for Wegovy and Zepbound without insurance is roughly $1,000 to $1,349 per month. Direct cash programs can advertise lower entry pricing, such as NovoCare's $199 Wegovy tier.
Eligibility matters. The word “entry” signals that a reader should check the exact program terms. Do not assume that an advertised amount applies to every dose, every month, or every person unless the program confirms it.
Telehealth can add a membership
Ro's Wegovy offer illustrates why the full calculation matters. The medicine is listed at $199 per month and the membership is $149. Together, those listed parts total $348 per month. A fair comparison should place that combined amount beside offers that bundle service and medication differently.
Telehealth can be a route to evaluation and prescribing. It does not make an investigational drug approved, and it does not turn a compounded product into a generic version of a brand drug.
The compounded market changed
Some telehealth companies still sell compounded semaglutide for roughly $196 to $499 per month. The legal background is important. The FDA ended the shortage based compounding allowance for compounded semaglutide and tirzepatide. In March 2026, the agency warned 30 telehealth companies over compounded GLP-1 marketing.
Compounded products should not be described as generic Wegovy, Ozempic, Zepbound, or Mounjaro. Marketing language does not erase the legal and product differences. Readers should ask exactly what product is being offered, why compounding is permitted, and which qualified professional is responsible for care.
Retatrutide is not part of the legal compounded market. The FDA stated on October 1, 2026 that retatrutide cannot be used in compounding under federal law. There is no legal compounded retatrutide.
A checklist before paying
Price comparison works best when every offer is reduced to the same set of questions.
- What is the total recurring monthly charge?
- Is medication included, or billed separately?
- Is the advertised price an entry tier?
- Is there a membership fee?
- Is the medicine an approved brand product or a compounded product?
- What happens if the price or legal status changes?
- Who evaluates side effects and ongoing care?
- How do cancellation and refills work?
Do not let a countdown clock or outcome promise rush the decision. FTC rules require affiliate relationships to be disclosed clearly and conspicuously. A publisher or promoter may earn money from a recommendation, and affiliates can be personally liable for deceptive claims.
What demand tells us
US searches across the GLP-1 class exceed 3 million per month. Zepbound receives about 823,000 monthly searches, Ozempic about 550,000 to 673,000, and Mounjaro about 550,000. Strong demand helps explain why pricing ads and new services appear so quickly.
Demand does not confirm quality. Compare the complete price and the legal status, then discuss medical choices with a qualified health care professional.
The bottom line
The 2026 market stretches from $199 entry offers to brand list prices above $1,000 per month. Membership charges can change the comparison, and compounded pricing comes with important legal context. Get the total monthly amount in writing, identify the exact product, and never treat compounded as another word for generic.